[Treatment of thromboembolic conditions with thrombolytics and anticoagulants].
D000284:Administration, Oral; D000707:Anaphylaxis / Q000517:prevention & control; D000925:Anticoagulants / Q000008:administration & dosage / Q000627:therapeutic use*; D001728:Dicumarol / Q000627:therapeutic use; D004211:Disseminated Intravascular Coagulation / Q000188:drug therapy; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D011247:Pregnancy; D013300:Streptokinase / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D013923:Thromboembolism / Q000188:drug therapy*; D013997:Time Factors
D000925:Anticoagulants; D005343:Fibrinolytic Agents; D001728:Dicumarol; D006493:Heparin; D013300:Streptokinase
Leczenie stanów zakrzepowo-zatorowych środkami trombolitycznymi i przeciwkrzepliwymi